Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gauri Sunkersett
Pharmacyclics LLC.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
48 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Center for Children. the Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Queensland Children'S Hospital
South Brisbane, Queensland, Australia
- the Royal Children'S Hospital
Parkville, Victoria, Australia
- Sydney Children'S Hospital
Randwick, Australia
- St. Anna Kinderspital
Vienna, Austria
- Children'S and Women'S Health Centre of British Columbia
Vancouver, British Columbia, Canada
- Chu Sainte-Justine
Montreal, Quebec, Canada
- Chu Nantes - Hopital Enfant Adolescent
Nantes, France
- Hôpital Robert-Debré Ap-Hp
Paris, France
- Charite-Universitaetsmedizin Berlin
Berlin, Germany
- Hadassah Medical Centre
Jerusalem, Israel
- Schneider Children'S Medical Center in Israel
Petah Tikva, Israel
- the Edmond and Lily Safra Children'S Hospital
Ramat Gan, Israel
- U.O.C. Ematologia Oncoematologia Pediatrica
Pavia, PV, Italy
- Fondazione Mbbm-Clinica Pediatrica
Monza, Italy
- Dipartimento Di Onco-Ematologia E Terapia Cellulare E Genica
Roma, Italy
- S.C. Farmacia Pediatrica - Presidio Ospedaliero Infantile Regina Margherita
Turin, Italy
- Princess Maxima Center
Utrecht, Netherlands
- Federal State Budgetary Institution "dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
Moscow, Russia
- Federal State Budgetary Educational Institution of Higher Professional Education "lp.Pavlov First Saint Petersburg State Medical
Saint Petersburg, Russia
- Asan Medical Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Seoul Saint Mary'S Hospital
Seoul, South Korea
- Hospital Universitario Vall D'Hebron
Barcelona, Spain
- Hospital Infantil Universitario Nino Jesus
Madrid, Spain
- Hospital Universitario Universitario la Paz
Madrid, Spain
- Safari Day Care, Great Ormond Street Hospital
London, Greater London, United Kingdom
- City of Hope
Duarte, California, United States
- Rady Children'S Hospital
San Diego, California, United States
- University of California
San Francisco, California, United States
- Children'S Hospital
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Ann & Robert H Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Minnesota Masonic Children'S Hospital
Minneapolis, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Nov 2018
- Primary completion
- 9 Oct 2025
- Completion
- 9 Oct 2025
- Last update posted
- 21 Oct 2025
- Registered enrollment
- 59
- Registry id
- NCT03790332
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.